China Agency Cuts Prices Of Cancer, Other Major Drugs By Average 17%
This article was originally published in PharmAsia News
Executive Summary
China's planning agency said that as of Oct. 8, the price caps of more than 200 drug formulations, including those for treating cancer and the immune and blood systems, would be lowered by an average of 17%.